Search Results - "DAURIAC, Charles"

Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies by DAMAJ, Gandhi, DUHAMEL, Alain, BULABOIS, Claude-Eric, HUYNH, Anne, BAY, Jacques-Olivier, LEGRAND, Faeyzeh, DECONINCK, Eric, FEGUEUX, Nathalie, CLEMENT, Laurence, DAURIAC, Charles, MAILLARD, Natacha, CORNILLON, Jérôme, ROBIN, Marie, ADES, Lionel, GUILLERM, Gaelle, SCHMIDT-TANGUY, Aline, MARJANOVIC, Zora, PARK, Sophie, RUBIO, Marie-Thérèse, MAROLLEAU, Jean-Pierre, GARNIER, Federico, FENAUX, Pierre, YAKOUB-AGHA, Ibrahim, BEGUIN, Yves, MICHALLET, Mauricette, MOHTY, Mohamad, VIGOUROUX, Stephane, BORIES, Pierre, GARNIER, Alice, EL CHEIKH, Jean

“…To investigate the impact of prior-to-transplantation azacitidine (AZA) on patient outcome after allogeneic stem-cell transplantation (alloSCT) for…”
Get full text

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia by Khellaf, Mehdi, Viallard, Jean-François, Hamidou, Mohamed, Cheze, Stéphane, Roudot-Thoraval, Françoise, Lefrere, François, Fain, Olivier, Audia, Sylvain, Abgrall, Jean-François, Michot, Jean-Marie, Dauriac, Charles, Lefort, Sophie, Gyan, Emmanuel, Niault, Mathilde, Durand, Jean-Marc, Languille, Laetitia, Boutboul, David, Bierling, Philippe, Michel, Marc, Godeau, Bertrand

“…Romiplostim and eltrombopag, the first thrombopoietic receptor-agonists with demonstrated efficacy against immune thrombocytopenia in prospective controlled…”
Get full text

Decreased Nonrelapse Mortality after Unrelated Cord Blood Transplantation for Acute Myeloid Leukemia Using Reduced-Intensity Conditioning: A Prospective Phase II Multicenter Trial by Rio, Bernard, Chevret, Sylvie, Vigouroux, Stéphane, Chevallier, Patrice, Fürst, Sabine, Sirvent, Anne, Bay, Jacques-Olivier, Socié, Gérard, Ceballos, Patrice, Huynh, Anne, Cornillon, Jérôme, Françoise, Sylvie, Legrand, Faezeh, Yakoub-Agha, Ibrahim, Michel, Gérard, Maillard, Natacha, Margueritte, Geneviève, Maury, Sébastien, Uzunov, Madalina, Bulabois, Claude Eric, Michallet, Mauricette, Clement, Laurence, Dauriac, Charles, Bilger, Karin, Gluckman, Eliane, Ruggeri, Annalisa, Buzyn, Agnès, Nguyen, Stéphanie, Simon, Tabassome, Milpied, Nöel, Rocha, Vanderson

“…Abstract A prospective phase II multicenter trial was performed with the aim to obtain less than 25% nonrelapse mortality (NRM) after unrelated cord blood…”
Get full text

Oncogenetic landscape of lymphomagenesis in coeliac disease by Cording, Sascha, Lhermitte, Ludovic, Malamut, Georgia, Berrabah, Sofia, Trinquand, Amélie, Guegan, Nicolas, Villarese, Patrick, Kaltenbach, Sophie, Meresse, Bertrand, Khater, Sherine, Dussiot, Michael, Bras, Marc, Cheminant, Morgane, Tesson, Bruno, Bole-Feysot, Christine, Bruneau, Julie, Molina, Thierry Jo, Sibon, David, Macintyre, Elizabeth, Hermine, Olivier, Cellier, Christophe, Asnafi, Vahid, Cerf-Bensussan, Nadine

“…Enteropathy-associated T-cell lymphoma (EATL) is a rare but severe complication of coeliac disease (CeD), often preceded by low-grade clonal intraepithelial…”
Get more information

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome by Royer, Bruno, Minvielle, Stéphane, Diouf, Momar, Roussel, Murielle, Karlin, Lionel, Hulin, Cyrille, Arnulf, Bertrand, Macro, Margaret, Cailleres, Sylvie, Brion, Annie, Brechignac, Sabine, Belhadj, Karim, Chretien, Marie Lorraine, Wetterwald, Marc, Chaleteix, Carine, Tiab, Mourad, Leleu, Xavier, Frenzel, Laurent, Garderet, Laurent, Choquet, Sylvain, Fuzibet, Jean Gabriel, Dauriac, Charles, Forneker, Luc-Matthieu, Benboubker, Lotfi, Facon, Thierry, Moreau, Philippe, Avet-Loiseau, Hervé, Marolleau, Jean Pierre

“…Primary plasma cell leukemia (pPCL) is a rare and aggressive malignancy with a poor prognosis. With conventional chemotherapy, patients typically die within 1…”
Get full text

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia by Letestu, Rémi, Dahmani, Abdelmalek, Boubaya, Marouane, Baseggio, Lucile, Campos, Lydia, Chatelain, Bernard, Debliquis, Agathe, Drénou, Bernard, Jacob, Marie-Christine, Legac, Eric, Le Garff-Tavernier, Magali, Lhoumeau, Anne-Catherine, Quiney, Claire, Robillard, Nelly, Ticchioni, Michel, Aanei, Carmen, Katsahian, Sandrine, Delepine, Roselyne, Vaudaux, Sandrine, Rouillé, Valérie, Béné, Marie-Christine, Dartigeas, Caroline, Van Den Neste, Eric, Leprêtre, Stéphane, Feugier, Pierre, Cartron, Guillaume, Leblond, Véronique, Lévy, Vincent, Cymbalista, Florence

“…Measurable residual disease (MRD) status is widely adopted in clinical trials in patients with chronic lymphocytic leukemia (CLL). Findings from FILO group…”
Get full text

NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study by Cheminant, Morgane, Bruneau, Julie, Malamut, Georgia, Sibon, David, Guegan, Nicolas, van Gils, Tom, Cording, Sascha, Trinquand, Amélie, Verkarre, Virginie, Lhermitte, Ludovic, Brousse, Nicole, Jannot, Anne-Sophie, Khater, Sherine, Frenzel, Laurent, Delarue, Richard, Suarez, Felipe, Marçais, Ambroise, Mulder, Chris Jj, Macintyre, Elizabeth, Asnafi, Vahid, Pouyet, Laurent, Bonnafous, Cécile, Lhospice, Florence, Molina, Thierry Jo, Meresse, Bertrand, Cellier, Christophe, Cerf-Bensussan, Nadine, Hermine, Olivier

“…Primary GI T-cell lymphoproliferative diseases (T-LPD) are heterogeneous entities, which raise difficult diagnosis and therapeutic challenges. We have recently…”
Get more information

MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs by Leleu, Xavier, Rodon, Philippe, Hulin, Cyrille, Daley, Laurent, Dauriac, Charles, Hacini, Maya, Decaux, Olivier, Eisemann, Jean-Claude, Fitoussi, Olivier, Lioure, Bruno, Voillat, Laurent, Slama, Borhane, Al Jijakli, Ahmad, Benramdane, Riad, Chaleteix, Carinne, Costello, Régis, Thyss, Antoine, Mathiot, Claire, Boyle, Eileen, Maloisel, Frédéric, Stoppa, Anne-Marie, Kolb, Brigitte, Michallet, Mauricette, Lamblin, Anne, Natta, Patrick, Facon, Thierry, Elalamy, Ismail, Fermand, Jean-Paul, Moreau, Philippe

“…Immunomodulatory drugs (IMiDs) are associated with an increased risk of venous thromboembolism (VTE) in multiple myeloma (MM) patients. We designed MELISSE, a…”
Get more information

Impact of ELN recommendations in the management of first‐line treated chronic myeloid leukaemia patients: a French cross‐sectional study by Etienne, Gabriel, Huguet, Francoise, Guerci‐Bresler, Agnès, Nicolini, Franck E., Maloisel, Frédéric, Coiteux, Valérie, Dauriac, Charles, Carpentier, Nathalie, Bourdeix, Isabelle, Tulliez, Michel, Cony‐Makhoul, Pascale

“…Summary The availability of tyrosine kinase inhibitors has extended therapeutic options for chronic myeloid leukaemia (CML) patients. Monitoring…”
Get full text

Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire by Decroocq, Justine, Itzykson, Raphaël, Vigouroux, Stéphane, Michallet, Mauricette, Yakoub‐Agha, Ibrahim, Huynh, Anne, Beckerich, Florence, Suarez, Felipe, Chevallier, Patrice, Nguyen‐Quoc, Stéphanie, Ledoux, Marie‐Pierre, Clement, Laurence, Hicheri, Yosr, Guillerm, Gaëlle, Cornillon, Jérôme, Contentin, Nathalie, Carre, Martin, Maillard, Natacha, Mercier, Mélanie, Mohty, Mohamad, Beguin, Yves, Bourhis, Jean‐Henri, Charbonnier, Amandine, Dauriac, Charles, Bay, Jacques‐Olivier, Blaise, Didier, Deconinck, Eric, Jubert, Charlotte, Raus, Nicole, Peffault de Latour, Regis, Dhedin, Nathalie

“…Patients with acute myeloid leukemia (AML) in relapse or refractory to induction therapy have a dismal prognosis. Allogeneic hematopoietic stem cell…”
Get full text

Management of Chemotherapy‐induced Anemia (CIA) with Biosimilar Epoetin Alfa (Binocrit®) in Patients with Multiple Myeloma (MM): An Interim Analysis of an Ongoing French National Observational Study (The OncoBOS study) by Voronina, Irina, Ojeda-Urib, Mario, Dauriac, Charles, Voillat, Laurent, Aubron-Olivier, Camille, Fernet, Domitille, Karlin, Lionel, Fitoussi, Olivier

“…Background: OncoBOS is a national, prospective, non-interventional, longitudinal, observational study describing biosimilar epoetin alfa (Binocrit®) use in…”
Get full text

Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC Study by Caulier, Alexis, Drumez, Elodie, Robin, Marie, Blaise, Didier, Beguin, Yves, Michallet, Mauricette, Chevallier, Patrice, Bay, Jacques-Olivier, Vigouroux, Stéphane, Desbrosses, Yohan, Cornillon, Jérôme, Nguyen, Stephanie, Peffault De Latour, Regis, Dauriac, Charles, Lioure, Bruno, Rohrlich, Pierre Simon, Carré, Martin, Bourhis, Jean-Henri, Huynh, Anne, Suarez, Felipe, Garnier, Federico, Duhamel, Alain, Yakoub-Agha, Ibrahim

“…INTRODUCTION Allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative option for high-risk myelodysplastic syndrome (MDS). Yet, allo-HCT…”
Get full text

Long Term Follow-up of Hematopoietic Stem Cell Transplantation (HSCT) for Primary Plasma Cell Leukemia (pPCL): Final Results of a Prospective Study of IFM Group by Royer, Bruno, Diouf, Momar, Roussel, Murielle, Karlin, Lionel, Hulin, Cyrille, Arnulf, Bertrand, Macro, Margaret, Cailleres, Sylvie, Brion, Annie, Brechignac, Sabine, Belhadj, Karim, Chretien, Marie Lorraine, Wetterwald, Marc, Chaleteix, Carine, Tiab, Mourad, Leleu, Xavier, Frenzel, Laurent, Garderet, Laurent, Choquet, Sylvain, Fuzibet, jean Gabriel, Dauriac, Charles, Fornecker, luc-Matthieu, Benboubker, Lotfi, Facon, Thierry, Moreau, Philippe, Avet Loiseau, Herve, Minvielle, Stephane, Marolleau, Jean Pierre

“…Introduction: pPCLis a rare form of multiple myeloma (MM) with very poor outcome. Current strategies including novel agents and transplantation (auto or…”
Get full text

Outcome Analysis of High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation in Patients with Hodgkin Lymphoma: A Francophone Society of Bone Marrow Transplantation and Cellular Therapy Study by Dulery, Remy, Reman, Oumedaly, Boumemdil, Ariane, Bouabdallah, Reda, Brice, Pauline, Gastinne, Thomas, Tabrizi, Reza, Quittet, Philippe, Huynh, Anne, Salles, Gilles, Monjanel, Helene, Stamatoullas, Aspasia, Bourhis, Jean-Henri, Bonmati, Caroline, Francois, Sylvie, Nguyen Quoc, Stephanie, Bay, Jacques Olivier, Cahn, Jean-Yves, Turlure, Pascal, Dauriac, Charles, Mohty, Mohamad, Peffault De Latour, Regis, Yakoub-Agha, Ibrahim

“…Background Many patients with relapsed or refractory Hodgkin's lymphoma (HL) undergo high-dose chemotherapy (HDC) and autologous stem cell transplantation…”
Get full text

Bortezomib-doxorubicin-cyclophosphamide-dexamethasone induction followed by stem cell transplantation for primary plasma cell leukemia: a prospective phase II study of the IFM by Royer, Bruno, Stéphane, Minvielle, Diouf, Momar, Roussel, Murielle, Karlin, Lionel, Hulin, Cyrille, Arnulf, Bertrand, Macro, Margaret, Sylvie, Cailleres, Brion, Annie, Bréchignac, Sabine, Karim, Beladj, Chrétien, Marie Lorraine, Wetterwald, Marc, Chaleteix, Carine, Tiab, Mourad, Leleu, Xavier, Frenzel, Laurent, Garderet, Laurent, Choquet, Sylvain, Fuzibet, Jean-Gabriel, Dauriac, Charles, Forneker, Luc-Matthieu, Benboubker, Lotfi, Facon, Thierry, Moreau, Philippe, Avet-Loiseau, Hervé, Marolleau, Jean-Pierre

“…PurposePrimary plasma cell leukemia (pPCL) is a rare and aggressive malignancy with a poor prognosis. With conventional chemotherapy, patients typically die…”
Get full text

Impact of NK Cell Reconstitution and Recipient HLA-C Typing on Clinical Outcome after Reduced Intensity Cord Blood Transplant: Results of a Prospective Phase II Multicentric Trial on Behalf of Societe Francaise De Greffe De Moelle Osseuse Et Therapie Cellulaire (SFGM-TC) and Eurocord by Nguyen, Stephanie, Souchet, Laetitia, Achour, Abla, Vigouroux, Stéphane, Chevallier, Patrice, Furst, Sabine, Sirvent, Anne, Bay, Jacques-Olivier, Socie, Gerard, Ceballos, Patrice, Huynh, Anne, Cornillon, Jérôme, Francois, Sylvie, Legrand, Faezeh, Yakoub-Agha, Ibrahim, Michel, Gerard, Maillard, Natacha, Margueritte, Genevieve, Maury, Sébastien, Uzunov, Madalina, Bulabois, Claude-Eric, Michallet, Mauricette, Clément, Laurence, Dauriac, Charles, Bilger, Karin, Lejeune, Julie, Beziat, Vivien, Rocha, Vanderson, Rio, Bernard, Chevret, Sylvie, Vieillard, Vincent

“…Background: Unrelated cord blood transplantation (UCBT) after reduced intensity conditioning regimen (RIC) has extended the use of UCB in elderly and unfit…”
Get full text

Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellula by Decroocq, Justine, Itzykson, Raphaël, Vigouroux, Stéphane, Michallet, Mauricette, Yakoub-Agha, Ibrahim, Huynh, Anne, Beckerich, Florence, Suarez, Felipe, Chevallier, Patrice, Nguyen-Quoc, Stephanie, Ledoux, Marie-Pierre, Clement, Laurence, Hicheri, Yosr, Guillerm, Gaelle, Cornillon, Jérôme, Contentin, Nathalie, Carre, Martin, Maillard, Natacha, Mercier, Mélanie, Mohty, Mohamad, Beguin, Yves, Bourhis, Jean-Henri, Charbonnier, Amandine, Dauriac, Charles, Bay, Jacques-Olivier, Blaise, Didier, Deconinck, Eric, Jubert, Charlotte, Raus, Nicole, Peffault de Latour, Régis, Dhédin, Nathalie

Get full text

Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study by Chaoui, Driss, Hacini, Maya, Fitoussi, Olivier, Karlin, Lionel, Arkam, Yazid, Jourdan, Eric, Orfeuvre, Hubert, Voillat, Laurent, Sanhes, Laurence, Leprêtre, Stéphane, Liu, Kun Lun, Barry, Marly, Tempescul, Adrian, Dilhuydy, Marie-Sarah, Chaib, Abdelaziz, Slama, Borhane, Labourey, Jean Luc, Benbrahim, Omar, Dreyfus, Brigitte, Mahé, Béatrice, Maynadié, Marc, Delmer, Alain, Benkanoun, Chahinez, Boissard, Frédéric, Gandon, Sophie, Veerabudun, Kalaivani, Choquet, Sylvain

Get full text

Allogeneic Hematopoietic Stem Cell Transplantation Offers Similar Outcome after Myeloablative and Sequential Conditioning Regimen in Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) by Decroocq, Justine, Itzykson, Raphael, Vigouroux, Stéphane, Michallet, Mauricette, Yakoub-Agha, Ibrahim, Beckerich, Florence, Huynh, Anne, Suarez, Felipe, Chevallier, Patrice, Nguyen quoc, Stephanie, Lioure, Bruno, Clément, Laurence, Fegueux, Nathalie, Contentin, Nathalie, Guillerm, Gaelle, Cornillon, Jérôme, Carré, Martin, Maillard, Natacha, Mercier, Mélanie, Mohty, Mohamad, Beguin, Yves, Bourhis, Jean-Henri, Charbonnier, Amandine, Jubert, Charlotte, Dauriac, Charles, Bay, Jacques-Olivier, Blaise, Didier, Deconinck, Eric, Raus, Nicole, Peffault de la Tour, Regis, Dhedin, Nathalie

“…Introduction: Acute myeloid leukemia (AML) patients failing to achieve complete remission or relapsing after intensive chemotherapy, have a dismal prognosis…”
Get full text

Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC by Caulier, Alexis, Drumez, Elodie, Gauthier, Jordan, Robin, Marie, Blaise, Didier, Beguin, Yves, Michallet, Mauricette, Chevallier, Patrice, Bay, Jacques-Olivier, Vigouroux, Stéphane, Desbrosses, Yohan, Cornillon, Jérôme, Nguyen, Stéphanie, Dauriac, Charles, de Latour, Régis Peffault, Lioure, Bruno, Rohrlich, Pierre-Simon, Carré, Martin, Bourhis, Jean-Henri, Huynh, Anne, Suarez, Felipe, Garnier, Federico, Duhamel, Alain, Yakoub-Agha, Ibrahim

“…We developed a prognostic scoring system to evaluate the prognosis of myelodysplastic syndrome (MDS) patients surviving more than 100 days allogeneic…”
Get full text